ArticleOphthalmology and therapy2022

Three-Year Outcomes of Intravitreal Aflibercept Injections for Retinal Angiomatous Proliferation According to Disease Stage.

Ya-Yun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.